Emerging Anti-Atherosclerotic Therapies
Cardiovascular disease (CAD) is the main cause of morbidity and deaths in the western world. The development of atherosclerosis underlying CAD development begins early in human life. There are numerous genetic and environmental risk factors accelerating its progression which then leads to the occurr...
Guardado en:
Autores principales: | Anna Gluba-Brzózka, Beata Franczyk, Magdalena Rysz-Górzyńska, Janusz Ławiński, Jacek Rysz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e000468eb9b41a18ac3139d50f89430 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efecto de un inhibidor tirosina kinasa (imatinib) en pacientes con tumores estromales gastrointestinales metastásicos: Experiencia preliminar
por: Garrido S,Marcelo, et al.
Publicado: (2007) -
Pseudophosphatases as Regulators of MAPK Signaling
por: Emma Marie Wilber Hepworth, et al.
Publicado: (2021) -
Role of JNK and ERK1/2 MAPK signaling pathway in testicular injury of rats induced by di-N-butyl-phthalate (DBP)
por: Wang,Hongyan, et al.
Publicado: (2019) -
The Unfolded Protein Response Regulates Pathogenic Development of <named-content content-type="genus-species">Ustilago maydis</named-content> by Rok1-Dependent Inhibition of Mating-Type Signaling
por: Lara Schmitz, et al.
Publicado: (2019) -
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study
por: Gordon D, et al.
Publicado: (2021)